Dietary Supplement Sector Warnings Jump With FDA 'Program Alignment'

Some stakeholders complained FDA inspectors unfamiliar with Part 111 inappropriately held supplement firms to drug or food product manufacturing regulations, but the agency's assignment of inspectors with greater expertise on the regulations could be turning up compliance problems in the sector that other ORA officials might have missed.

More from Regulation

More from Policy & Regulation